| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Upstream Bio, Inc. | Director | Common Stock | 4,554,873 | 15 Oct 2024 | Indirect | ||
| Upstream Bio, Inc. | Director | Stock Option (Right to Buy) | 17,096 | 10 Jun 2025 | Direct | ||
| Upstream Bio, Inc. | Director | Series A redeemable convertible preferred stock | 0 | 15 Oct 2024 | Indirect | ||
| Upstream Bio, Inc. | Director | Series B redeemable convertible preferred stock | 0 | 15 Oct 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| UPB | Upstream Bio, Inc. | 10 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 16:17 |
| UPB | Upstream Bio, Inc. | 15 Oct 2024 | 8 | +$14,025,000 | 4 | Director, 10%+ Owner | 17 Oct 2024, 16:19 |
| UPB | Upstream Bio, Inc. | 10 Oct 2024 | 1 | $0 | 4 | Director | 15 Oct 2024, 16:15 |
| UPB | Upstream Bio, Inc. | 10 Oct 2024 | 0 | $0 | 3 | Director, 10%+ Owner | 10 Oct 2024, 20:33 |